Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 15 de may. de 2024 · Aldactone se utiliza para reducir la tensión arterial elevada (hipertensión), la hinchazón por acumulación de líquidos (edemas) que causan ciertas enfermedades del riñón, hígado o del corazón y en el tratamiento de la insuficiencia cardiaca en combinación con otros medicamentos utilizados.

  2. Hace 4 días · Spironolactone, sold under the brand name Aldactone among others, is a diuretic medication primarily used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It is also used in the treatment of high blood pressure , and low blood potassium that does not improve with supplementation .

    • C₂₄H₃₂O₄S
    • Aldactone, others
    • AU: B3
  3. 1 de may. de 2024 · Spironolactone is also used to diagnose and treat hyperaldosteronism, a condition in which the adrenal gland produces too much hormone called aldosterone. This medicine may also be used to treat fluid retention (edema) in patients with congestive heart failure, liver cirrhosis, or a kidney disorder called nephrotic syndrome.

  4. Adults—At first, 75 milligrams (mg) (15 milliliters [mL]) per day, taken in either single or divided doses. Your doctor may adjust your dose as needed. Children—Use and dose must be determined by your doctor. For oral dosage form (tablets): Adults—At first, 100 milligrams (mg) per day, taken in either single or divided doses.

  5. 17 de may. de 2024 · Precio ALDACTONE 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 50 comprimidos: PVP 2.50 Euros. con aportación especial (17 de Mayo de 2024). Laboratorio: PFIZER S.L. . Sistema de clasificación Anatómico, Terapéutica, Química (ATC) del medicamento: Grupo Anatómico principal: SISTEMA CARDIOVASCULAR .

  6. 12 de may. de 2024 · We pooled individual patient data from the RALES (Randomized Aldactone Evaluation Study) and EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure) trials. The association between MRA treatment and outcomes was assessed according to whether the estimated glomerular filtration rate (eGFR) declined to <30 mL/min/1.73 m 2 or not.

  1. Otras búsquedas realizadas